Key result
Resveratrol effectively reduced total cholesterol, triglycerides, low-density lipoprotein cholesterol, and atherogenic index in hyperlipidemic mice in a dose-dependent manner.
Why the study?
Does resveratrol reduce blood lipid levels in hyperlipidemic mice?
Does resveratrol reduce blood lipid levels in hyperlipidemic mice?
Resveratrol demonstrates a dose-dependent reduction in blood lipid levels in a hyperlipidemic mouse model.
Answers are grounded in this paper and cite their sources.
Supports preclinical lipid research in mice; leaves open translation to human hyperlipidemia pending clinical trials.
BACKGROUND: The content of resveratrol is relatively high in Polygonum cuspidatum Sieb. et Zucc., and the resveratrol has the effect of blood vessel dilating, microcirculation improving, platelet aggregation inhibiting and anti-cancer. The objective of this paper was to study the effect of resveratrol on lipid metabolism in hyperlipidemia mice. MATERIALS AND METHODS: Through the establishment of an experimental mouse model of hyperlipidemia, the effect of resveratrol on change in total cholesterol (TC), triglyceride (TG), high density lipoprotein cholesterol (HDL-c), and low-density lipoprotein cholesterol (LDL-c) levels in mouse serum were determined. RESULTS: Resveratrol group can apparently reduce TC, TG, LDL-c and AI of hyperlipidemic mice in a dose effect manner. CONCLUSION: We concluded that resveratrol can effectively reduce blood lipid levels of hyperlipidemic mice.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2013) studied Hyperlipidemia. Resveratrol was evaluated on Change in total cholesterol (TC), triglyceride (TG), high density lipoprotein cholesterol (HDL-c), and low-density lipoprotein cholesterol (LDL-c) levels. Resveratrol effectively reduced total cholesterol, triglycerides, low-density lipoprotein cholesterol, and atherogenic index in hyperlipidemic mice in a dose-dependent manner.
Synapse has enriched 10 related papers. Consider them for comparative context: